Nipent pentostatin cancer data

Data from an open-label, U.K. trial in 219 patients comparing pentostatin to cladribine showed

Read the full 140 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE